AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,952,217 | +9.9% | 4,486,726 | +1.4% | 0.15% | +16.4% |
| Q2 2023 | $206,597,457 | +41.7% | 4,425,119 | +16.1% | 0.13% | +33.3% |
| Q1 2023 | $145,826,409 | -20.3% | 3,811,676 | +14.1% | 0.10% | -26.7% |
| Q4 2022 | $183,028,260 | +25.6% | 3,340,174 | -60.9% | 0.13% | +20.2% |
| Q3 2022 | $145,737,592 | +402.6% | 8,550,918 | +178.7% | 0.11% | +445.0% |
| Q2 2022 | $28,994,000 | -39.4% | 3,068,312 | -8.9% | 0.02% | -13.0% |
| Q1 2022 | $47,806,000 | -28.6% | 3,368,662 | +6.5% | 0.02% | -17.9% |
| Q4 2021 | $66,921,000 | -7.4% | 3,163,622 | -2.2% | 0.03% | -12.5% |
| Q3 2021 | $72,306,000 | -16.4% | 3,234,987 | -7.2% | 0.03% | -13.5% |
| Q2 2021 | $86,528,000 | -14.4% | 3,487,495 | +0.1% | 0.04% | -19.6% |
| Q1 2021 | $101,029,000 | +12.1% | 3,482,665 | -0.3% | 0.05% | +9.5% |
| Q4 2020 | $90,136,000 | -17.2% | 3,493,419 | -1.2% | 0.04% | -26.3% |
| Q3 2020 | $108,856,000 | +59.5% | 3,535,455 | +29.1% | 0.06% | +50.0% |
| Q2 2020 | $68,231,000 | +16.3% | 2,738,518 | -1.0% | 0.04% | -5.0% |
| Q1 2020 | $58,656,000 | +9.7% | 2,766,820 | +14.8% | 0.04% | +48.1% |
| Q4 2019 | $53,478,000 | +19.9% | 2,409,533 | +18.7% | 0.03% | +12.5% |
| Q3 2019 | $44,603,000 | +206.0% | 2,030,028 | +166.7% | 0.02% | +200.0% |
| Q2 2019 | $14,578,000 | – | 761,153 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |